Skip to main content
Year archive

ArcticZymes Technologies — 2016 filings

All 80 regulatory filings released by ArcticZymes Technologies (AZT) in 2016, sourced directly from the official regulator.

80 Filings
2016 Period
2016 filings (80)
Filing Released Lang
Biotec Pharmacon: Kjøp av egne aksjer for videresalg til ansatte
Transaction in Own Shares
2016-11-09 Norwegian
Biotec Pharmacon: Kjøp av egne aksjer for videresalg til ansatte
Director's Dealing
2016-11-09 Norwegian
Biotec Pharmacon: Kjøp av egne aksjer for videresalg til ansatte
Transaction in Own Shares
2016-11-09 Norwegian
Finansiell kalender
Report Publication Announcement
2016-11-03 Norwegian
Financial calendar
Report Publication Announcement
2016-11-03 English
Biotec Pharmacon: Q3 2016 Results
Report Publication Announcement Q3 2016
2016-10-26 English
Biotec Pharmacon: Q3 2016 Results
Interim / Quarterly Report Q3 2016
2016-10-26 English
Biotec Pharmacon: Q3 2016 Results
Earnings Release Q3 2016
2016-10-26 English
Biotec Pharmacon: Q3 2016 Presentation
Report Publication Announcement
2016-10-26 English
Biotec Pharmacon: Q3 2016 Resultater
Earnings Release Q3 2016
2016-10-26 Norwegian
Biotec Pharmacon: Q3 2016 Resultater
Earnings Release Q3 2016
2016-10-26 Norwegian
First homecare customer in Germany
Regulatory Filings
2016-10-24 English
First homecare customer in Germany
Regulatory Filings
2016-10-24 English
Biotec Pharmacon ASA: Invitation to presentation of Q3 2016 results
Report Publication Announcement
2016-10-18 Norwegian
Biotec Pharmacon ASA: Invitation to presentation of Q3 2016 results
Report Publication Announcement
2016-10-18 English
ArcticZymes launches its first Polymerase product and has been granted patent protection on its heat-labile Salt Active Nuclease in the USA
Regulatory Filings
2016-09-30 English
ArcticZymes launches its first Polymerase product and has been granted patent protection on its heat-labile Salt Active Nuclease in the USA
Regulatory Filings
2016-09-30 English
Confirmation of German reimbursement in 2nd region and additional questions from UK Drug Tariff
Regulatory Filings
2016-09-19 English
Confirmation of German reimbursement in 2nd region and additional questions from UK Drug Tariff
Regulatory Filings
2016-09-19 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2016-09-07 English
Biotec Pharmacon: Q2 2016 Results
Earnings Release Q2 2016
2016-08-17 English
Biotec Pharmacon: Q2 2016 Resultater
Report Publication Announcement
2016-08-17 Norwegian
Biotec Pharmacon: Q2 2016 Presentation
Investor Presentation
2016-08-17 English
Biotec Pharmacon: Q2 2016 Resultater
Earnings Release Q2 2016
2016-08-17 Norwegian
Biotec Pharmacon: Q2 2016 Presentation
Report Publication Announcement
2016-08-17 English
Biotec Pharmacon ASA: Invitation to presentation of Q2 2016 results
Report Publication Announcement
2016-08-09 English
Biotec Pharmacon - mandatory notification of trade
Director's Dealing
2016-07-01 English
Market update - Commercialization Woulgan
Regulatory Filings
2016-06-30 English
Market update - Commercialization Woulgan
Regulatory Filings
2016-06-30 English
Biotec fikk fullt medhold i voldgiftssak
Legal Proceedings Report
2016-06-13 Norwegian
Biotec fikk fullt medhold i voldgiftssak
Legal Proceedings Report
2016-06-13 Norwegian
Biotec cleared in arbitration matter
Legal Proceedings Report
2016-06-13 English
Enters into German distribution agreement for Woulgan®
Regulatory Filings
2016-06-13 English
Inngår distribusjonsavtale for Woulgan® i Tyskland
Regulatory Filings
2016-06-13 Norwegian
Enters into German distribution agreement for Woulgan®
Regulatory Filings
2016-06-13 English
Inngår distribusjonsavtale for Woulgan® i Tyskland
Regulatory Filings
2016-06-13 Norwegian
Biotec Pharmacon: Meldepliktig handel
Director's Dealing
2016-06-03 Norwegian
Biotec Pharmacon will present at Anglonordic Life Science Conference
Investor Presentation
2016-05-19 English
Biotec Pharmacon will present at Anglonordic Life Science Conference
Report Publication Announcement
2016-05-19 English
Biotec Pharmacon tildeler opsjoner til alle ansatte
Director's Dealing
2016-05-12 Norwegian
Biotec Pharmacon ASA - Protokoll fra ordinær generalforsamling 2016
AGM Information
2016-05-11 Norwegian
Biotec Pharmacon ASA - Protokoll fra ordinær generalforsamling 2016
AGM Information
2016-05-11 Norwegian
Biotec Pharmacon ASA - Flagging av fullmakter til generalforsamling
Proxy Solicitation & Information Statement
2016-05-11 Norwegian
Biotec Pharmacon: Q1 2016 Results
Earnings Release Q1 2016
2016-04-19 English
Biotec Pharmacon: Q1 2016 Results
Interim / Quarterly Report Q1 2016
2016-04-19 English
Biotec Pharmacon: Resultater Q1 2016
Earnings Release Q1 2016
2016-04-19 Norwegian
Biotec Pharmacon: Q1 2016 Results
Earnings Release Q1 2016
2016-04-19 English
Biotec Pharmacon: Q1 2016 Presentation
Investor Presentation
2016-04-19 English
Biotec Pharmacon: Q1 2016 Presentation
Report Publication Announcement
2016-04-19 English
Årsrapport 2015 Biotec Pharmacon
Annual Report FY 2015
2016-04-18 Norwegian
Årsrapport 2015 Biotec Pharmacon
Report Publication Announcement
2016-04-18 Norwegian
Innkalling til ordinær generalforsamling i Biotec Pharmacon ASA
AGM Information
2016-04-18 Norwegian
Innkalling til ordinær generalforsamling i Biotec Pharmacon ASA
AGM Information
2016-04-18 Norwegian
Innkalling til ordinær generalforsamling i Biotec Pharmacon ASA
AGM Information
2016-04-18 Norwegian
Biotec Pharmacon ASA: Invitation to presentation of Q1 2016 results
Report Publication Announcement
2016-04-12 English
ArcticZymes awarded funding from the Horizon2020 programme
Capital/Financing Update
2016-04-01 English
ArcticZymes awarded funding from the Horizon2020 programme
Capital/Financing Update
2016-04-01 English
ArcticZymes tildelt forskningsstøtte fra EUs Horizon 2020 program
Regulatory Filings
2016-04-01 Norwegian
ArcticZymes tildelt forskningsstøtte fra EUs Horizon 2020 program
Regulatory Filings
2016-04-01 Norwegian
Biotec Pharmacon ASA - flaggemelding
Director's Dealing
2016-03-30 Norwegian
Biotec Pharmacon will present at Carnegie Healthcare Seminar
Investor Presentation
2016-03-17 English
Biotec Pharmacon will present at Carnegie Healthcare Seminar
Report Publication Announcement
2016-03-17 English
Biotec BetaGlucans har inngått leverandøravtale for salg av M-Glucan
Regulatory Filings
2016-03-11 Norwegian
Biotec BetaGlucans har inngått leverandøravtale for salg av M-Glucan
Regulatory Filings
2016-03-11 Norwegian
Biotec BetaGlucans has entered into supply agreement for delivery of M-Glucan
Regulatory Filings
2016-03-11 English
Biotec BetaGlucans has entered into supply agreement for delivery of M-Glucan
Regulatory Filings
2016-03-11 English
Biotec Pharmacon has received "Notice of Allowance" for Woulgan gel in the US
Regulatory Filings
2016-03-03 English
Biotec Pharmacon: Capital Markets Day 2016
Report Publication Announcement
2016-02-11 English
Biotec Pharmacon: Capital Markets Day 2016
Investor Presentation
2016-02-11 English
Biotec Pharmacon: Capital Markets Day 2016
AGM Information
2016-02-11 English
Biotec Pharmacon: Q4 2015 Results and presentation
Interim / Quarterly Report Q4 2015
2016-02-11 English
Biotec Pharmacon: Q4 2015 Results and presentation
Investor Presentation
2016-02-11 English
Biotec Pharmacon: Q4 2015 Results and presentation
Report Publication Announcement
2016-02-11 English
Biotec Pharmacon: Kapitalmarkedsdag 2016
Investor Presentation
2016-02-11 Norwegian
Biotec Pharmacon: Kapitalmarkedsdag 2016
Regulatory Filings
2016-02-11 Norwegian
Biotec Pharmacon: Invitation to Q4 2015 presentation and Capital Markets Day
Investor Presentation
2016-02-03 English
Biotec Pharmacon: Invitation to Q4 2015 presentation and Capital Markets Day
Report Publication Announcement
2016-02-03 English
Signed supplier agreement with NutraQ AS for 2016
Regulatory Filings
2016-01-19 Norwegian
Signed supplier agreement with NutraQ AS for 2016
Regulatory Filings
2016-01-19 English
Biotec Pharmacon: Meldepliktig handel
Director's Dealing
2016-01-14 Norwegian